6-K

QuickLinks -- Click here to rapidly navigate through this document

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934

August 17, 2004

Commission File Number 001-11145

BIOVAIL CORPORATION
(Translation of Registrant's name into English)

7150 Mississauga Road, Mississauga, Ontario, CANADA, L5N 8M5
(Address of principal executive office and zip code)

Registrant's telephone number, including area code: (905) 286-3000

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ý Form 40-F o

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1).

Yes o No ý

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7).

Yes o No ý

Indicate by check mark whether by furnishing the information contained in this form the registrant is also hereby furnishing the information to the Commission pursuant to Rule 12g 3-2(b) under the Securities Exchange Act of 1934.

Yes o No ý

BIOVAIL CORPORATION
QUARTERLY REPORT

This Report of Foreign Private Issuer on Form 6-K is incorporated by reference into the registration statement on Form S-8 (Registration No. 333-92229) of Biovail Corporation.

INDEX

Exhibit 99.1 — Report of Voting Results — June 25, 2004 Annual and Special Meeting of Shareholders

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Biovail Corporation
Date: August 17, 2004
	By:	/s/  JOHN R. MISZUK John R. Miszuk Vice President, Controller and Assistant Secretary

QuickLinks

BIOVAIL CORPORATION QUARTERLY REPORT
INDEX
SIGNATURES

EX-99.1

QuickLinks -- Click here to rapidly navigate through this document

Exhibit 99.1

BIOVAIL CORPORATION
Annual and Special Meeting of Shareholders
June 25, 2004
REPORT OF VOTING RESULTS

Pursuant to Section 11.3 of National Instrument 51-102 (Continuous Disclosure Obligations), this report describes the matters voted upon, and the outcomes of the votes conducted, at the 2004 Annual and Special Meeting of Shareholders of Biovail Corporation ("Biovail") held on Friday June 25, 2004.

1.    Election of Directors

The following nominees of management were acclaimed as directors of Biovail for a term expiring at the conclusion of the next annual meeting of the shareholders of Biovail or until their successors are elected or appointed:

Eugene N. Melnyk
Rolf K. Reininghaus
Wilfred G. Bristow
Roger D. Rowan
Laurence E. Paul
Sheldon Plener
Michael Van Every

2.    Appointment of Auditor

Ernst & Young LLP were appointed as the auditor of Biovail and its subsidiaries and the directors of Biovail were authorized to fix the remuneration of the auditor by a vote on this matter by way of a show of hands.

3.    2004 Stock Option Plan

The adoption of Biovail's 2004 Stock Option Plan was approved by a ballot vote on this matter. The results of the ballot were as follows:

	Number of Votes	Percentage
FOR:	66,234,210	77%
AGAINST:	19,760,696	23%

DATED: June 28, 2004

BIOVAIL CORPORATION
By:	/s/  JOHN MISZUKJohn Miszuk Vice President, Controller and Assistant Secretary

QuickLinks

BIOVAIL CORPORATION Annual and Special Meeting of Shareholders June 25, 2004 REPORT OF VOTING RESULTS